Sarilumab by Regeneron Pharmaceuticals for Polyarticular Juvenile Idiopathic Arthritis (PJIA): Likelihood of Approval

Sarilumab is under clinical development by Regeneron Pharmaceuticals and currently in Pre-Registration for Polyarticular Juvenile Idiopathic Arthritis (PJIA).

Dandelion Health Launches Pilot to Evaluate Healthcare Algorithm Bias & Equity

What You Should Know: Dandelion Health, Inc., a startup offering a healthcare data platform that specializes in artificial intelligence and precision analytics, announced today the

June 30, 2023

State-Regulated Psychedelics ‘On A Collision Course’ With FDA, Says Harvard Law Expert

A new article authored by renowned regulatory specialist Dr. Mason Marks, of the Project on Psychedelics Law and Regulation at Harvard Law School, highlights growing concern about the chasm between

December 13, 2023

GC Cell and PT Bifarma to launch T-cell therapy in Indonesia

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.